Silver Lake Research
- Diagnostics
- Other R&D services
- Biotech or pharma, animal health
Silver Lake Research is a leading innovator in rapid detection, harnessing advanced antibody development and proprietary LFA technology to deliver breakthrough immunodiagnostics. Our EAP™ Immunization System generates MAbs that others cannot, and our EAP-based diagnostics are unmatched or unique in each addressed application. Our product portfolio includes:
HemoType™ - point-of-care tests for Sickle Cell Disease (β-Thalassemia and other hemoglobinopathies in the pipeline);
RapidBac™ - rapid, culture-free tests for bacteria in urine (rapid AMR tests in the pipeline);
Watersafe™ - hypersensitive immunoassays for heavy metals and other contaminants (multiple tests in the pipeline).
In addition, we have completed >75 contract development projects to produce custom antibodies, immunoassays, and OEM products for strategic partners. With R&D and manufacturing together in our FDA-registered and ISO-certified facilities in the USA, we offer complete, turn-key CDMO solutions.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}